All updated as on -
By 2030, the global 3D bioprinting market is predicted to be worth $5.6 billion, a 23.4% CAGR between 2023 and 2030.
The industry is being propelled forward by factors such as the scarcity of organ donors and the rising prevalence of chronic respiratory diseases among the elderly. Furthermore, the rising prevalence of chronic diseases, technological advancements, and increased funding for R&D are all contributing to the market's expected expansion over the next several years.
Additive manufacturing, such as 3D bioprinting, employs 3D printing to create biomedical components that mimic the properties of genuine tissue. Layer-by-layer deposition of bioinks facilitates the creation of tissue-based structures with broad applications in the domains of tissue and medical engineering, as is the case with 3D bioprinting. Bioprinting, preparatory work, and analysis are all part of the 3D bioprinting process. Organ and tissue constructs created by 3D bioprinting are used in a wide variety of fields, including drug discovery, medical device design, and tissue engineering. The printing scaffolds used in ligament and joint regeneration have also been adopted by the field of 3D bioprinting. Because of this, tremendous progress has been made in the tissue engineering domains through the study of biomaterials and other novel materials.
The increasing application of 3D bioprinting in industries like biotechnology, pharmaceuticals, and healthcare points to a bright future for the worldwide 3D Bioprinting Market during the next years. The global 3D bioprinting market is anticipated to expand during the forecast period on account of factors such as the rising use of 3D printing in cosmetic surgery and innovations in the field. The business has also been propelled by rising commercial and public financing for bioprinting research.
The development of 3D bioprinting technology for a variety of medical applications, such as cancer therapies, tissue development, liver modelling, and bone and cartilage development, is expected to propel the 3D bioprinting market forward in the coming years. In addition, we also discuss the many current trends in innovation within the 3D bioprinting industry. Clinical trial applications and drug testing using 3D bioprinting are key to fulfilling the goal of reducing the need for animal experiments.
Report Coverage
Global 3D Bioprinting research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global 3D Bioprinting report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and 3D Bioprinting competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key 3D Bioprinting market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global 3D Bioprinting market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, 3D Bioprinting market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global 3D Bioprinting market based on the below-mentioned segments:
Global 3D Bioprinting Market, By Technology
Global 3D Bioprinting market, By Application
Global 3D Bioprinting market, Regional Analysis
The industry is being propelled forward by factors such as the scarcity of organ donors and the rising prevalence of chronic respiratory diseases among the elderly. Furthermore, the rising prevalence of chronic diseases, technological advancements, and increased funding for R&D are all contributing to the market's expected expansion over the next several years.
Additive manufacturing, such as 3D bioprinting, employs 3D printing to create biomedical components that mimic the properties of genuine tissue. Layer-by-layer deposition of bioinks facilitates the creation of tissue-based structures with broad applications in the domains of tissue and medical engineering, as is the case with 3D bioprinting. Bioprinting, preparatory work, and analysis are all part of the 3D bioprinting process. Organ and tissue constructs created by 3D bioprinting are used in a wide variety of fields, including drug discovery, medical device design, and tissue engineering. The printing scaffolds used in ligament and joint regeneration have also been adopted by the field of 3D bioprinting. Because of this, tremendous progress has been made in the tissue engineering domains through the study of biomaterials and other novel materials.
The increasing application of 3D bioprinting in industries like biotechnology, pharmaceuticals, and healthcare points to a bright future for the worldwide 3D Bioprinting Market during the next years. The global 3D bioprinting market is anticipated to expand during the forecast period on account of factors such as the rising use of 3D printing in cosmetic surgery and innovations in the field. The business has also been propelled by rising commercial and public financing for bioprinting research.
The development of 3D bioprinting technology for a variety of medical applications, such as cancer therapies, tissue development, liver modelling, and bone and cartilage development, is expected to propel the 3D bioprinting market forward in the coming years. In addition, we also discuss the many current trends in innovation within the 3D bioprinting industry. Clinical trial applications and drug testing using 3D bioprinting are key to fulfilling the goal of reducing the need for animal experiments.
Report Coverage
Global 3D Bioprinting research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global 3D Bioprinting report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and 3D Bioprinting competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key 3D Bioprinting market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2020 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2019 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Organovo Holdings, Inc., Envisiontec GmbH, Nano 3D Biosciences, Inc., Regenhu Ltd., Cellink, Vivax Bio, LLC, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Advanced Solutions Life Sciences, LLC, Pandorum Technologies pvt., Foldink Life Science Technologies, Precise Bio |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of 3D Bioprinting Market from 2021 to 2030.
- Market Forecast for 3D Bioprinting Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, 3D Bioprinting competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on 3D Bioprinting
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global 3D Bioprinting market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, 3D Bioprinting market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
- Organovo Holdings, Inc.
- Envisiontec GmbH
- Nano 3D Biosciences, Inc.
- Cyfuse Biomedical K.K.
- Regenhu Ltd.
- Aspect Biosystems Ltd.
- Biobots
- Cellink
- Gesim
- Poietis
- Vivax Bio, LLC
- Allevi
- Cyfuse Biomedical K.K.
- 3D Bioprinting Solutions
- Cellink Global
- Regemat 3D S.L.
- Bico group ab,
- Collplant Biotechnologies Ltd.
- Advanced Solutions Life Sciences, LLC
- Rokit Healthcare, inc.
- Pandorum Technologies pvt. ltd.
- Foldink Life Science Technologies
- Revotek co., ltd.
- Precise Bio
Primary Target Market
- Market Players of 3D Bioprinting
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global 3D Bioprinting market based on the below-mentioned segments:
Global 3D Bioprinting Market, By Technology
- Magnetic Levitation
- Inkjet-based
Global 3D Bioprinting market, By Application
- Medical
- Dental
- Biosensors
- Bioinks
Global 3D Bioprinting market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive 3d bioprinting market market research and competitor analysis for your business to help you develop more profound insights into the 3d bioprinting market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the 3d bioprinting market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.